A Study Evaluating SYHX2005 in the Treatment of Patients With Advanced Solid Tumors

NCT05609019 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

139

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SYHX2005

Sponsor

CSPC Ouyi Pharmaceutical Co., Ltd.